Ocotillol Enhanced the Antitumor Activity of Doxorubicin via p53-Dependent Apoptosis

Cardioprotective Effects of 20(S)-Ginsenoside Rh2 against Doxorubicin-Induced CardiotoxicityIn VitroandIn Vivo

(2012) Hongbo Wang et al.   Evidence-based Complementary and Alternative Medicine

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer

(2011) Jessica M. Scott et al.   CIRCULATION

Therapeutic Potential of Ginseng in the Management of Cardiovascular Disorders

(2011) Morris Karmazyn et al.   DRUGS

Systemic treatment of non-small-cell lung cancer

(2011) Rohit Lal et al.   EUROPEAN JOURNAL OF CANCER

Curcumin enhanced adriamycin-induced human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagy

(2011) Haoran Qian et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Ginsenosides from American ginseng: Chemical and pharmacological diversity

(2011) Lian-Wen Qi et al.   PHYTOCHEMISTRY

Pharmacological Rescue of p53 in Cancer Therapy: Widening the Sensitive Tumor Spectrum by Targeting MDMX

(2010) Jean-Christophe Marine   CANCER CELL

Anticancer Properties of Indole Compounds: Mechanism of Apoptosis Induction and Role in Chemotherapy

(2010) Aamir Ahmad et al.   CURRENT DRUG TARGETS

A Small-Molecule Inhibitor of MDMX Activates p53 and Induces Apoptosis

(2010) H. Wang et al.   MOLECULAR CANCER THERAPEUTICS

Doxorubicin: The Good, the Bad and the Ugly Effect

(2009) Cristina Carvalho et al.   CURRENT MEDICINAL CHEMISTRY

Lx2-32c, a novel taxane and its antitumor activities in vitro and in vivo

(2008) Hongbo Wang et al.   CANCER LETTERS

Evasion of Ribonuclease Inhibitor as a Determinant of Ribonuclease Cytotoxicity

(2008) Thomas Rutkoski et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY